A prospective phase II randomized trial of proton radiotherapy vs intensity-modulated radiotherapy for patients with newly diagnosed glioblastoma

Paul D Brown, Caroline Chung, Diane D Liu, Sarah McAvoy, David Grosshans, Karine Al Feghali, Anita Mahajan, Jing Li, Susan L McGovern, Mary-Fran McAleer, Amol J Ghia, Erik P Sulman, Marta Penas-Prado, John F de Groot, Amy B Heimberger, Jihong Wang, Terri S Armstrong, Mark R Gilbert, Nandita Guha-Thakurta, Jeffrey S Wefel

Open source

DOI: 10.1093/neuonc/noab040
Published: 2021-02-27
Container: Neuro-Oncology
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/neuonc/noab040,
  title = {A prospective phase II randomized trial of proton radiotherapy vs intensity-modulated radiotherapy for patients with newly diagnosed glioblastoma},
  author = {Paul D Brown and Caroline Chung and Diane D Liu and Sarah McAvoy and David Grosshans and Karine Al Feghali and Anita Mahajan and Jing Li and Susan L McGovern and Mary-Fran McAleer and Amol J Ghia and Erik P Sulman and Marta Penas-Prado and John F de Groot and Amy B Heimberger and Jihong Wang and Terri S Armstrong and Mark R Gilbert and Nandita Guha-Thakurta and Jeffrey S Wefel},
  year = {2021},
  journal = {Neuro-Oncology},
  doi = {10.1093/neuonc/noab040},
  url = {https://doi.org/10.1093/neuonc/noab040}
}

RIS

TY  - JOUR
TI  - A prospective phase II randomized trial of proton radiotherapy vs intensity-modulated radiotherapy for patients with newly diagnosed glioblastoma
AU  - Paul D Brown
AU  - Caroline Chung
AU  - Diane D Liu
AU  - Sarah McAvoy
AU  - David Grosshans
AU  - Karine Al Feghali
AU  - Anita Mahajan
AU  - Jing Li
AU  - Susan L McGovern
AU  - Mary-Fran McAleer
AU  - Amol J Ghia
AU  - Erik P Sulman
AU  - Marta Penas-Prado
AU  - John F de Groot
AU  - Amy B Heimberger
AU  - Jihong Wang
AU  - Terri S Armstrong
AU  - Mark R Gilbert
AU  - Nandita Guha-Thakurta
AU  - Jeffrey S Wefel
PY  - 2021
JO  - Neuro-Oncology
DO  - 10.1093/neuonc/noab040
UR  - https://doi.org/10.1093/neuonc/noab040
ER  -

APA

Brown, P. D., Chung, C., Liu, D. D., McAvoy, S., Grosshans, D., Feghali, K. A., Mahajan, A., Li, J., McGovern, S. L., McAleer, M., Ghia, A. J., Sulman, E. P., Penas-Prado, M., Groot, J. F. D., Heimberger, A. B., Wang, J., Armstrong, T. S., Gilbert, M. R., Guha-Thakurta, N., & Wefel, J. S. (2021). A prospective phase II randomized trial of proton radiotherapy vs intensity-modulated radiotherapy for patients with newly diagnosed glioblastoma. Neuro-Oncology. https://doi.org/10.1093/neuonc/noab040

Source records

crossref · retrieved 2026-09-26T17:05:37.083Z